Table IV.
Postoperative outcomes
| CMSG (n = 69) | PMSG (n = 28) | Overall (N = 97) | |
|---|---|---|---|
| 30-Day mortality | 3 (4) | 4 (14) | 7 (7) |
| In-hospital mortality | 3 (4) | 4 (14) | 7 (7) |
| Cause of death | |||
| Myocardial infarction | 0 (0) | 1 (3.5) | 1 (1) |
| Stroke | 0 (0) | 1 (3.5) | 1 (1) |
| Bowel or colonic ischemia | 2 (3) | 1 (3.5) | 3 (3) |
| Pulmonary infection | 0 (0) | 1 (3.5) | 1 (1) |
| Access infection | 1 (1) | 0 (0) | 1 (1) |
| Patients presenting with ≥1 nonfatal complication | 15 (22) | 7 (25) | 22 (23) |
| Total of nonfatal postoperative complications | 16 | 8 | 24 |
| Stroke | 1 (1) | 0 (0) | 1 (1) |
| Spinal cord ischemia | 3 (4) | 2 (7) | 5 (5) |
| Definitive | 1 (1) | 0 (0) | 1 (1) |
| Partially regressive | 0 (0) | 1 (3.5) | 1 (1) |
| Totally regressive | 2 (3) | 1 (3.5) | 3 (3) |
| Renal failure requiring hemodialysis | 1 (1) | 0 (0) | 1 (1) |
| Bowel or colonic ischemia | 3 (4) | 0 (0) | 3 (3) |
| Severe acute respiratory syndrome | 2 (3) | 0 (0) | 2 (2) |
| Transient renal failure | 4 (6) | 4 (14) | 8 (8) |
| Hemorrhage | 1 (1) | 2 (7) | 3 (3) |
| Access site infection | 1 (1) | 0 (0) | 1 (1) |
CMSG, Custom-made stent graft; PMSG, physician-modified stent graft.
Values are reported as number (%).